Ideal Cardiovascular Health Is Inversely Associated with Nonalcoholic Fatty Liver Disease: A Prospective Analysis

被引:27
|
作者
Wang, Long
Li, Mian
Zhao, Zhiyun
Xu, Min
Lu, Jieli
Wang, Tiange
Chen, Yuhong
Wang, Shuangyuan
Dai, Meng
Hou, Yanan
Wu, Xueyan
Ma, Lina
Li, Lin
Liu, Shanshan
Wang, Weiqing
Xu, Yu
Bi, Yufang
Ning, Guang
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Endocrine & Metab Dis, Natl Clin Res Ctr Metab Dis,Rui Jin Hosp, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Endocrine & Metab Dis, Shanghai, Peoples R China
来源
AMERICAN JOURNAL OF MEDICINE | 2018年 / 131卷 / 12期
基金
中国国家自然科学基金; 国家重点研发计划;
关键词
Cardiovascular health; Cohori; Nonalcoholic fatty liver disease; Prevention; FIBROSIS SCORE; NAFLD; RISK; PREVALENCE; MORTALITY; PREDICTOR;
D O I
10.1016/j.amjmed.2018.07.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Cardiovascular health has been proven to be associated with major cardiometabolic diseases. However, little is known of associations between cardiovascular health and nonalcoholic fatty liver disease. METHODS: This study included 3424 adults aged >= 40 years who were free of nonalcoholic fatty liver disease at baseline from a community cohort followed for up to 5 years. Liver ultrasonography was conducted at baseline and at follow-up to diagnose incident nonalcoholic fatty liver disease. Six metrics including smoking, physical activity, body mass index, total cholesterol, blood pressure, and fasting glucose were used to define cardiovascular health status. Associations of individual cardiovascular health metrics, number of cardiovascular health metrics, and overall cardiovascular health status at baseline, as well as changes in cardiovascular health during follow-up with risks of developing nonalcoholic fatty liver disease, were examined. RESULTS: A total of 649 participants developed nonalcoholic fatty liver disease during follow-up. Risks of nonalcoholic fatty liver disease reduced in a dose response manner in participants with 3-4 ideal cardiovascular health metrics (odds ratio 0.50; 95% confidence interval, 0.41-0.61) and in participants with 5-6 ideal metrics (odds ratio 0.34; 95% confidence interval 0.22-0.51) compared with participants with 0-2 ideal metrics. An overall ideal or intermediate cardiovascular health was associated with 37% reduction in developing nonalcoholic fatty liver disease compared with poor cardiovascular health. In addition, improving cardiovascular health during follow-up reduced the risk by 71% compared with deteriorating cardiovascular health. Furthermore, an overall ideal or intermediate cardiovascular health was significantly associated with a lower fibrosis score in nonalcoholic fatty liver disease patients compared with an overall poor cardiovascular health. CONCLUSIONS: Ideal cardiovascular health was inversely associated with risks of nonalcoholic fatty liver disease. Although treatment of nonalcoholic fatty liver disease and subsequent inflammation and fibrosis remains a challenge, cardiovascular health goals should be advocated for nonalcoholic fatty liver disease prevention. (C) 2018 Published by Elsevier Inc.
引用
收藏
页码:1515.e1 / 1515.e10
页数:10
相关论文
共 50 条
  • [41] Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
    Targher, Giovanni
    Day, Christopher P.
    Bonora, Enzo
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (14): : 1341 - 1350
  • [42] Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease
    Alessandro Mantovani
    Stefano Ballestri
    Amedeo Lonardo
    Giovanni Targher
    Digestive Diseases and Sciences, 2016, 61 : 1246 - 1267
  • [43] Higher fructose intake is inversely associated with risk of nonalcoholic fatty liver disease in older Finnish adults
    Kanerva, Noora
    Sandboge, Samuel
    Kaartinen, Niina E.
    Mannisto, Satu
    Eriksson, Johan G.
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2014, 100 (04): : 1133 - 1138
  • [44] Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease
    Mantovani, Alessandro
    Ballestri, Stefano
    Lonardo, Amedeo
    Targher, Giovanni
    DIGESTIVE DISEASES AND SCIENCES, 2016, 61 (05) : 1246 - 1267
  • [45] Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease
    Masahide Hamaguchi
    Takao Kojima
    Noriyuki Takeda
    Chisato Nagata
    Jun Takeda
    Hiroshi Sarui
    Yutaka Kawahito
    Naohisa Yoshida
    Atsushi Suetsugu
    Takahiro Kato
    Junichi Okuda
    Kazunori Ida
    Toshikazu Yoshikawa
    World Journal of Gastroenterology, 2007, (10) : 1579 - 1584
  • [46] Nonalcoholic Fatty Liver Disease and Severity of Cardiovascular Disease Manifestations
    Athyros, Vasilios G.
    Katsiki, Niki
    Karagiannis, Asterios
    ANGIOLOGY, 2013, 64 (08) : 572 - 575
  • [47] Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: Causation or Association
    Bali, Atul D.
    Rosenzveig, Akiva
    Frishman, William H.
    Aronow, Wilbert S.
    CARDIOLOGY IN REVIEW, 2024, 32 (05) : 453 - 462
  • [48] GALLSTONE DISEASE IS NOT ASSOCIATED WITH LIVER FIBROSIS AND NONALCOHOLIC STEATOHEPATITIS IN NONALCOHOLIC FATTY LIVER DISEASE
    Yilmaz, Y.
    Ayyildiz, T.
    Akin, H.
    Colak, Y.
    Ozturk, O.
    Senates, E.
    Tuncer, I.
    Dolar, E.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S553 - S554
  • [49] CARDIOVASCULAR RISK IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE
    Ceasovschih, A.
    Sorodoc, V.
    Lionte, C.
    Statescu, C.
    Sascau, R. A.
    Aursulesei, V. Onofrei
    Haliga, R. E.
    Bologa, C.
    Stoica, A.
    Sirbu, O.
    Coman, A. E.
    Grigorescu, E. -D.
    Petris, O. R.
    Pavel, M.
    Constantin, M.
    Diaconu, A. -D.
    Morarasu, B. C.
    Rusu-Zota, G.
    Profire, B.
    Culis, N.
    Clim, A.
    Sorodoc, L.
    ATHEROSCLEROSIS, 2023, 379 : S82 - S83
  • [50] Update on cardiovascular risk in nonalcoholic fatty liver disease
    Johnston, Michael P.
    Patel, Janisha
    Byrne, Christopher D.
    CURRENT OPINION IN CARDIOLOGY, 2021, 36 (04) : 478 - 486